Smart stethoscope for monitoring the effectiveness of treatments to shatter kidney stones

NewsGuard 100/100 Score

Professor Tim Leighton from the University of Southampton's world-renowned Institute of Sound and Vibration Research (ISVR) and Dr Andrew Coleman, of Guy's and St Thomas NHS Foundation Trust are developing with industry a 'smart stethoscope' for monitoring the effectiveness of treatments to shatter kidney stones.

The current procedure, called lithotripsy, focuses thousands of shock waves onto kidney stones in an effort to break them into small pieces which can then be dissolved by drugs or passed from the body in urine. However, it is difficult to discover exactly when the treatment has succeeded in breaking the stone and patients frequently have to experience more shocks than necessary.

The 'smart stethoscope' listens to the echoes, which reverberate around the body after each shock wave. The device has also been used clinically at the London hospitals Guys and St Thomas.

'It's an imperfect analogy, but consider a railwayman walking along the length of a train, hitting the metal wheels with a hammer,' explained Professor Leighton. 'If the wheel rings nicely, he knows that it's not cracked. If the wheel is cracked, it gives a duller sound.

'We are looking for the stone to go from being intact at the start of treatment (when it will give a nice ring "tick" sound) to being fragmented at the end of the treatment (when it will give a duller "tock" sound).'

A website containing recordings of these sounds, and other information on the project, is at www.isvr.soton.ac.uk/fdag/litho.htm

In addition to Professor Leighton and Dr Coleman, the team involved Dr Paul White of ISVR, Graham Ball of AWE, PhD students Fiammetta Fedele, Riza Jamaluddin and Cary Turangan and Andrew Hurrell of Precision Acoustics Ltd.

Commercial negotiations between the inventors, the University's Centre for Enterprise and Innovation and manufacturers of lithotripters are underway. The project was funded by the Engineering and Physical Science Research Council (EPSRC).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients